(Q42498089)

1 November 2017

title

Our PDT experience in the treatment of non-melanoma skin cancer over the last 7 years (English)

1 reference

1 November 2017

1 reference

Baptista J

1

1 reference

1 November 2017

Martinez C

series ordinal

2

1 reference

1 November 2017

Leite L

series ordinal

3

1 reference

1 November 2017

Cochito M

series ordinal

4

1 reference

1 November 2017

publication date

1 July 2006

1 reference

Journal of the European Academy of Dermatology and Venereology

1 November 2017

published in

1 reference

1 November 2017

volume

20

1 reference

1 November 2017

issue

6

1 reference

1 November 2017

page(s)

693-697

1 reference

Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01574.X

Induction of drug photosensitization in man after parenteral exposure to hematoporphyrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01574.X

Indurated telangiectatic plaques. Malignant angioendotheliomatosis (MAE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01574.X

Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01574.X

Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01574.X

Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01574.X

Topical photodynamic therapy in clinical dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01574.X

The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01574.X

Kinetics of the superficial perfusion and temperature in connection with photodynamic therapy of basal cell carcinomas using esterified and non-esterified 5-aminolaevulinic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01574.X

Irradiance and light dose influence histological localization of photodamage induced by photodynamic therapy with aminolaevulinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01574.X

In vitro/in vivo correlations between transdermal delivery of 5-aminolaevulinic acid and cutaneous protoporphyrin IX accumulation and effect of formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2006.01574.X

10.1111/J.1468-3083.2006.01574.X

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference